The Lp(a) HORIZON Trial: What We Learned and What's Next

Live Online Lecture
Wednesday, December 2, 2026, 6:00 PM - 7:00 PM EST

Description

Fresh from the American Heart Association's 2026 Scientific Sessions, join the American Society for Preventive Cardiology (ASPC) for a special CardioCore featuring Steven E. Nissen, MD, as he discusses the highly anticipated results of the landmark Lp(a) HORIZON trial. Despite achieving substantial reductions in lipoprotein(a), the trial did not demonstrate a corresponding reduction in major cardiovascular events, raising important questions about the role of Lp(a)-lowering therapies in cardiovascular prevention. Dr. Nissen will provide firsthand insights into the trial's findings, explore potential explanations for the unexpected results, and discuss their implications for clinical practice, ongoing research, and the future of Lp(a)-targeted therapies.

Lecturer

Erin Bohula, MD, DPhil
Steven E. Nissen, MD

Steven E. Nissen, MD, is Chief Academic Officer of the Heart and Vascular Institute at Cleveland Clinic, the Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at Cleveland Clinic Lerner College of Medicine. He previously served as Chair of Cardiovascular Medicine at Cleveland Clinic (2006–2019) and President of the American College of Cardiology (2006–2007).

Dr. Nissen is an internationally recognized cardiovascular researcher whose work focuses on atherosclerosis, lipid-lowering therapies, cardiovascular outcomes, and drug safety. He has led numerous major clinical trials and authored more than 700 scientific publications. His current research includes clinical trials evaluating emerging therapies for elevated lipoprotein(a).

A former member and chair of the FDA CardioRenal Advisory Panel, Dr. Nissen has also played a prominent role in drug safety and cardiovascular public policy. He was named one of Time Magazine’s 100 Most Influential People in 2007 and has been recognized among the world's most highly cited physician-scientists.

Moderator

Ashish Sarraju, MD, FASPC
Ashish Sarraju, MD, FASPC

Ashish Sarraju, MD, FASPC, is Associate Staff in Preventive Cardiology at the Miller Heart, Vascular, and Thoracic Institute at the Cleveland Clinic Cleveland Ohio, and a researcher with the Cleveland Clinic Coordinating Center for Clinical Research (C5research).

Dr. Sarraju trained at Stanford University as a resident and Chief Resident in internal medicine, where he stayed for fellowship and as Chief Fellow in Cardiovascular Medicine. He completed a postdoctoral research training funded by the American Heart Association focused on health tech and innovation. He received the Edwin Alderman award for Excellence in Clinical Research at Stanford. At the Cleveland Clinic, he focuses on dyslipidemias and familial hypercholesterolemia. His research focuses on clinical trials, epidemiologic studies, and AI and tech to address gaps in preventive cardiology.

His original research has been published in journals such as JAMA, Annals of Internal Medicine, Circulation, and JACC. He serves in leadership positions for phase 1 through 3 randomized trials. He is a member of C5research, the academic research organization of the Cleveland Clinic. He serves as a peer reviewer for major journals, on several AHA grant review committees, and is a member of the AHA Epidemiology and Prevention Statistics committee. He received a Top Educator award at the Cleveland Clinic in 2023.

Register now